UB Paderborn / Katalog / Suche / in CDI

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)

Cancers, 2022-06, Vol.14 (11), p.2771

2022

Volltextzugriff (PDF)

Low‐dose apixaban in extended treatment of cancer‐associated thrombosis: Less is more?

Journal of thrombosis and haemostasis, 2022-05, Vol.20 (5), p.1070-1072

2022

Volltextzugriff (PDF)

Screening for occult cancer: where are we in 2020?

Thrombosis research, 2020-07, Vol.191, p.S12-S16

2020

Volltextzugriff (PDF)

Prospective study to evaluate quality of life in amyotrophic lateral sclerosis

Scientific reports, 2023-07, Vol.13 (1), p.12074-12074, Article 12074

2023

Volltextzugriff (PDF)

Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study

American journal of clinical pathology, 2024-05, Vol.161 (5), p.501-511

2024

Volltextzugriff (PDF)

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism

Frontiers in cardiovascular medicine, 2023-05, Vol.10, p.1118385-1118385

2023

Volltextzugriff (PDF)

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism

Cancers, 2020-08, Vol.12 (8), p.2267

2020

Volltextzugriff (PDF)

Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

Archivos de bronconeumología (English ed.), 2019-12, Vol.55 (12), p.619-626

2019

Volltextzugriff (PDF)

Extended treatment of cancer-associated thrombosis

Thrombosis research, 2019-09, Vol.181, p.1-9

2019

Volltextzugriff (PDF)

Riesgo de recurrencia tras retirada de la anticoagulación en pacientes con enfermedad tromboembólica venosa no provocada: validación externa del nomograma de Viena y del modelo predictivo DASH

Archivos de bronconeumología, 2019-12, Vol.55 (12), p.619-626

2019

Volltextzugriff (PDF)

Comment on “Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE Registry”

International journal of cardiology, 2021-12, Vol.344, p.190-191

2021

Volltextzugriff (PDF)

Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis

British journal of cancer, 2022-12, Vol.127 (12), p.2234-2240

2022

Volltextzugriff (PDF)

Risk of Recurrence After Withdrawal of Anticoagulation in Patients With Unprovoked Venous Thromboembolism: External Validation of the Vienna Nomogram and the Dash Prediction Score

Archivos de bronconeumología (English ed.), 2019-12, Vol.55 (12), p.619-626

2019

Volltextzugriff (PDF)

Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study

Thrombosis research, 2022-03, Vol.211, p.81-84

2022

Volltextzugriff (PDF)

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

British journal of cancer, 2019-02, Vol.120 (4), p.473-474

2019

Volltextzugriff (PDF)

Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy

Research and practice in thrombosis and haemostasis, 2023-02, Vol.7 (2), p.100115, Article 100115

2023

Volltextzugriff (PDF)

Intermittent pneumatic compression plus pharmacological thromboprophylaxis to prevent deep vein thrombosis

Journal of thoracic disease, 2019-05, Vol.11 (5), p.1731-1733

2019

Volltextzugriff (PDF)

Análisis de las indicaciones y complicaciones de los pacientes con enfermedad tromboembólica venosa a los que se ha colocado filtro de vena cava inferior

Archivos de bronconeumología, 2021-06, Vol.57 (6), p.444-445

2021

Volltextzugriff (PDF)

Towards a precision medicine in venous thromboembolism associated to lung cancer

Journal of thoracic disease, 2018-09, Vol.10 (Suppl 26), p.S3064-S3066

2018

Volltextzugriff (PDF)

Analysis of the Indications and Complications of Vena Cava Filter in Patients with Venous Thromboembolism

Archivos de bronconeumologia, 2021-06, Vol.57 (6), p.444-445

2021

Volltextzugriff (PDF)

Analysis of the Indications and Complications of Vena Cava Filter in Patients with Venous Thromboembolism

Archivos de bronconeumología (English ed.), 2020-12

2020

Volltextzugriff (PDF)

A continuous-flow catalytic process with natural hematite-alginate beads for effective water decontamination and disinfection: Peroxymonosulfate activation leading to dominant sulfate radical and minor non-radical pathways

Chemical engineering journal (Lausanne, Switzerland : 1996), 2021-05, Vol.411, p.127738, Article 127738

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)

Low‐dose apixaban in extended treatment of cancer‐associated thrombosis: Less is more?

Screening for occult cancer: where are we in 2020?

Prospective study to evaluate quality of life in amyotrophic lateral sclerosis

Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism

Prognostic Significance of Incidental Deep Vein Thrombosis in Patients with Cancer Presenting with Incidental Pulmonary Embolism

Risk Of Recurrence After Withdrawal Of Anticoagulation In Patients With Unprovoked Venous Thromboembolism: External Validation Of The Vienna Nomogram And The Dash Prediction Score

Extended treatment of cancer-associated thrombosis

Riesgo de recurrencia tras retirada de la anticoagulación en pacientes con enfermedad tromboembólica venosa no provocada: validación externa del nomograma de Viena y del modelo predictivo DASH

Comment on “Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE Registry”

Low-molecular-weight heparin beyond 12 months in patients with cancer-associated thrombosis

Risk of Recurrence After Withdrawal of Anticoagulation in Patients With Unprovoked Venous Thromboembolism: External Validation of the Vienna Nomogram and the Dash Prediction Score

Venous thromboembolism in amyotrophic lateral sclerosis. A prospective quasi-experimental study

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'

Risk of recurrent cancer-associated thrombosis after discontinuation of anticoagulant therapy

Intermittent pneumatic compression plus pharmacological thromboprophylaxis to prevent deep vein thrombosis

Análisis de las indicaciones y complicaciones de los pacientes con enfermedad tromboembólica venosa a los que se ha colocado filtro de vena cava inferior

Towards a precision medicine in venous thromboembolism associated to lung cancer

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

Analysis of the Indications and Complications of Vena Cava Filter in Patients with Venous Thromboembolism

Analysis of the Indications and Complications of Vena Cava Filter in Patients with Venous Thromboembolism

A continuous-flow catalytic process with natural hematite-alginate beads for effective water decontamination and disinfection: Peroxymonosulfate activation leading to dominant sulfate radical and minor non-radical pathways

Suchergebnisse filtern